Pallidifloside D from Smilax riparia enhanced allopurinol effects in hyperuricemia mice.

[1]  Zhenzhong Wang,et al.  Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation. , 2014, The American journal of Chinese medicine.

[2]  J. Ruan,et al.  Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice. , 2014, Journal of ethnopharmacology.

[3]  Yong-Ki Park,et al.  Selective therapeutic effect of cornus officinalis fruits on the damage of different organs in STZ-induced diabetic rats. , 2014, The American journal of Chinese medicine.

[4]  B. Wani,et al.  Effect of Ajuga bracteosa on systemic T-cell immunity in Balb/C mice: dual Th1/Th2 immunostimulatory effects. , 2014, The American journal of Chinese medicine.

[5]  Jian-Mei Li,et al.  Betaine supplementation protects against high-fructose-induced renal injury in rats. , 2014, The Journal of nutritional biochemistry.

[6]  Xiao-hui Wu,et al.  Smilax riparia reduces hyperuricemia in mice as a potential treatment of gout. , 2014, The American journal of Chinese medicine.

[7]  X. Shao,et al.  Cardioprotection of vitexin on myocardial ischemia/reperfusion injury in rat via regulating inflammatory cytokines and MAPK pathway. , 2013, The American journal of Chinese medicine.

[8]  C. Zoccali,et al.  Uric Acid, Hypertension, and Cardiovascular and Renal Complications , 2013, Current Hypertension Reports.

[9]  Hui Ma,et al.  Tumoral cytotoxic and antioxidative phenylpropanoid glycosides in Smilax riparia A. DC. , 2013, Journal of ethnopharmacology.

[10]  Y. Bao,et al.  Cardio-protection by Ginkgo biloba extract 50 in rats with acute myocardial infarction is related to Na⁺-Ca²⁺ exchanger. , 2013, The American journal of Chinese medicine.

[11]  Chong-Zhi Wang,et al.  Trends in scientific publications of Chinese medicine. , 2012, The American journal of Chinese medicine.

[12]  Jian-Mei Li,et al.  Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice. , 2011, European journal of pharmacology.

[13]  A. Mally,et al.  Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. , 2010, Toxicology.

[14]  Kimoon Park,et al.  Reparatory and preventive effects of oriental herb extract mixture (OHEM) on hyperuricemia and gout , 2010 .

[15]  Zhen Ouyang,et al.  The dual actions of Sanmiao wan as a hypouricemic agent: down-regulation of hepatic XOD and renal mURAT1 in hyperuricemic mice. , 2010, Journal of ethnopharmacology.

[16]  T. Yeh,et al.  Allopurinol in Dermatology , 2010, American journal of clinical dermatology.

[17]  C. China Pharmacopoeia,et al.  Pharmacopoeia of the People's Republic of China , 2010 .

[18]  B. Thorens,et al.  Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy , 2009, Proceedings of the National Academy of Sciences.

[19]  P. Boffetta,et al.  A prospective study of gout and cancer , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[20]  W. R. Wikoff,et al.  Multiple organic anion transporters contribute to net renal excretion of uric acid. , 2008, Physiological genomics.

[21]  L. Naldi,et al.  Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. , 2008, Journal of the American Academy of Dermatology.

[22]  R. Torres,et al.  Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. , 2007, Metabolism: clinical and experimental.

[23]  N. Dalbeth,et al.  Allopurinol Dosing in Renal Impairment: Walking the Tightrope Between Adequate Urate Lowering and Adverse Events , 2007, Seminars in dialysis.

[24]  C. Szabó,et al.  Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol , 2006, Pharmacological Reviews.

[25]  A. Enomoto,et al.  Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease , 2005, Clinical and Experimental Nephrology.

[26]  T. Bardin.  Current management of gout in patients unresponsive or allergic to allopurinol. , 2004, Joint, bone, spine : revue du rhumatisme.

[27]  L. Kong,et al.  A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. , 2004, Journal of ethnopharmacology.

[28]  A. Enomoto,et al.  Function and localization of urate transporter 1 in mouse kidney. , 2004, Journal of the American Society of Nephrology : JASN.

[29]  H. Simmonds,et al.  Gout, uric acid and purine metabolism in paediatric nephrology , 1993, Pediatric Nephrology.

[30]  A. Takeuchi,et al.  Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1, rOAT3 and rOCT2. , 2003, Biochemical pharmacology.

[31]  R. Burgos-Vargas,et al.  Relation between adverse events associated with allopurinol and renal function in patients with gout , 2001, Annals of the rheumatic diseases.

[32]  M D Harris,et al.  Gout and hyperuricemia. , 1999, American family physician.

[33]  G. Mcinnes,et al.  Acute adverse reactions attributed to allopurinol in hospitalised patients. , 1981, Annals of the rheumatic diseases.